406 related articles for article (PubMed ID: 19764431)
21. [Implication of genetic polymorphism on neuropathic pain].
Iseki M; Sato-Takeda M
Masui; 2009 Sep; 58(9):1112-21. PubMed ID: 19764434
[TBL] [Abstract][Full Text] [Related]
22. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
Ruano G; Kost JA
Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacodynamics of pain perception and polymorphism].
Kikuchi H
Masui; 2009 Sep; 58(9):1084-5. PubMed ID: 19764429
[TBL] [Abstract][Full Text] [Related]
24. A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain.
Janicki PK; Schuler G; Francis D; Bohr A; Gordin V; Jarzembowski T; Ruiz-Velasco V; Mets B
Anesth Analg; 2006 Oct; 103(4):1011-7. PubMed ID: 17000822
[TBL] [Abstract][Full Text] [Related]
25. [Side effects of opioid and gene variants].
Sora I; Komatsu H; Igari M; Ide S; Ikeda K; Shimoyama N
Masui; 2009 Sep; 58(9):1109-11. PubMed ID: 19764433
[TBL] [Abstract][Full Text] [Related]
26. Are mu-opioid receptor polymorphisms important for clinical opioid therapy?
Lötsch J; Geisslinger G
Trends Mol Med; 2005 Feb; 11(2):82-9. PubMed ID: 15694871
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms and human sensitivity to opioid analgesics.
Nishizawa D; Hayashida M; Nagashima M; Koga H; Ikeda K
Methods Mol Biol; 2010; 617():395-420. PubMed ID: 20336437
[TBL] [Abstract][Full Text] [Related]
28. Genetics of pain, opioids, and opioid responsiveness.
Tremblay J; Hamet P
Metabolism; 2010 Oct; 59 Suppl 1():S5-8. PubMed ID: 20837195
[TBL] [Abstract][Full Text] [Related]
29. Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning.
Olesen AE; Grønlund D; Gram M; Skorpen F; Drewes AM; Klepstad P
BMC Res Notes; 2018 Jan; 11(1):78. PubMed ID: 29374492
[TBL] [Abstract][Full Text] [Related]
30. CYP2D6 in the metabolism of opioids for mild to moderate pain.
Leppert W
Pharmacology; 2011; 87(5-6):274-85. PubMed ID: 21494059
[TBL] [Abstract][Full Text] [Related]
31. Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model.
Nielsen LM; Christrup LL; Sato H; Drewes AM; Olesen AE
Basic Clin Pharmacol Toxicol; 2017 Jul; 121(1):6-12. PubMed ID: 28084056
[TBL] [Abstract][Full Text] [Related]
32. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
Crews KR; Monte AA; Huddart R; Caudle KE; Kharasch ED; Gaedigk A; Dunnenberger HM; Leeder JS; Callaghan JT; Samer CF; Klein TE; Haidar CE; Van Driest SL; Ruano G; Sangkuhl K; Cavallari LH; Müller DJ; Prows CA; Nagy M; Somogyi AA; Skaar TC
Clin Pharmacol Ther; 2021 Oct; 110(4):888-896. PubMed ID: 33387367
[TBL] [Abstract][Full Text] [Related]
33. [Pain and genetics].
Møller AT; Kølvraa S; Jensen TS
Ugeskr Laeger; 2006 May; 168(20):1944-7. PubMed ID: 16768888
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics and obstetric anesthesia.
Landau R
Int Anesthesiol Clin; 2007; 45(1):1-15. PubMed ID: 17215696
[No Abstract] [Full Text] [Related]
35. Genetics and variability in opioid response.
Stamer UM; Bayerer B; Stüber F
Eur J Pain; 2005 Apr; 9(2):101-4. PubMed ID: 15737794
[TBL] [Abstract][Full Text] [Related]
36. Catecholamine-o-methyltransferase polymorphisms are associated with postoperative pain intensity.
Lee PJ; Delaney P; Keogh J; Sleeman D; Shorten GD
Clin J Pain; 2011 Feb; 27(2):93-101. PubMed ID: 20842020
[TBL] [Abstract][Full Text] [Related]
37. Genetics. Unraveling pain's DNA.
Couzin J
Science; 2006 Oct; 314(5799):585-6. PubMed ID: 17068236
[No Abstract] [Full Text] [Related]
38. Opioids for chronic pain: molecular and genomic basis of actions and adverse effects.
Ahmedzai SH; Boland J
Curr Opin Support Palliat Care; 2007 Aug; 1(2):117-25. PubMed ID: 18685352
[TBL] [Abstract][Full Text] [Related]
39. High post surgical opioid requirements in Crohn's disease are not due to a general change in pain sensitivity.
Huehne K; Leis S; Muenster T; Wehrfritz A; Winter S; Maihöfner C; Foertsch T; Croner R; Reis A; Winterpacht A; Rautenstrauss B
Eur J Pain; 2009 Nov; 13(10):1036-42. PubMed ID: 19167252
[TBL] [Abstract][Full Text] [Related]
40. Cross-sectional assessment of the consequences of a GTP cyclohydrolase 1 haplotype for specialized tertiary outpatient pain care.
Doehring A; Freynhagen R; Griessinger N; Zimmermann M; Sittl R; Hentig Nv; Geisslinger G; Lötsch J
Clin J Pain; 2009; 25(9):781-5. PubMed ID: 19851158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
